Hopemark Health’s Post

Shedding Light on Bipolar Depression: How Light Therapy Offers New Hope Emerging research indicates that light therapy can help regulate circadian rhythms and alleviate symptoms of bipolar depression, providing a natural, non-invasive solution to manage this condition. https://lnkd.in/g_q6sjcN #BipolarDepression #LightTherapy #CircadianRhythm #MentalHealthTreatment #NaturalApproach #NonInvasive #MoodRegulation #CognitiveEnhancement #FatigueReduction #HopeForBipolarDisorder #MentalHealthInnovation #TherapeuticLight #WellnessTransformation

Happy to share this recent publication where we present findings that support the use of #groupbased #transdiagnostic #therapy for individuals living with #comorbid #mentalhealth conditions. This is important as individuals with mental health challenges seldom fit perfectly into one diagnosis and transdiagnostic approaches help those who is struggling with multiple diagnoses. We report on #personalrecovery which is an important patient outcome that is not as widely captured in medical research. Lynn Zhu, PhD Lindsay Slater MSW, RSW and Jane Mizevich https://lnkd.in/gNEMETNZ

Did you know that NeuroStar® Advanced Therapy stimulates nerve cells in mood-controlling areas of the brain—the same areas that are under-active in people suffering from depression? That means NeuroStar treats depression right at the source, for better and more accurate results. Contact TMS Institute of Ohio today at 419-627-9289 to learn how you can start treatment with one of the most powerful depression therapies available. *Visit NeuroStar.com for full safety and prescribing information. #depression #depressionawareness #mentalhealthadvocate #mentalhealthwarrior #mentalhealthawareness #mentalhealthmatters #NeuroStar #NeuroStarCares #BeANeuroStar #TMS #mentalhealth #depressionhelp #endstigma #mentalillness #mentalwellness #mentalhealthrecovery #mentalhealthsupport

🚀 Diversifying Psychiatric Treatments: A Dual Perspective The world of psychiatric treatments is rapidly evolving. While traditional methods remain effective, there's a growing need to diversify and embrace advanced therapies. Here's why: 1️⃣ Ketamine Therapy: Once an anesthetic, now a promising treatment for various mental illnesses. 2️⃣ TMS Therapy: A non-invasive approach targeting specific brain regions, offering a tailored experience. 3️⃣ SPRAVATO Treatment: An FDA-approved nasal spray derivative of ketamine. 4️⃣ Psychedelic Assisted Therapy: Rediscovering the profound therapeutic potential of psychedelics. 5️⃣ Theta Burst Stimulation: The next wave in TMS, offering targeted mood regulation. Diversifying isn't just about revenue; it's a commitment to holistic patient care. By embracing these therapies, clinics can be at the forefront of mental health treatment, offering renewed hope. 🔗 Dive deeper into the therapeutic and revenue potential of these treatments: [Link to the article] #PsychiatricTreatments #MentalHealth #Innovation #PracticeRP https://lnkd.in/g6bC8ANW

Is there a need for Oral Fluid detection of psych medications and hallucinogens? Is there a need for blood spot identification of these drugs? As method developers we are evaluating the need and functionality of theses methods. We have them in our blood and urine methods already. #hallucinogen #psychedelics #psychological health #Oral-fluids #bloodtesting

Breaking down misconceptions about electroconvulsive therapy (ECT). In our latest blog, we learn how this treatment offers hope and relief for individuals battling severe depression, bipolar disorder, and more. https://sbhc.tech/4cAA7Ao

ALCOHOL USE DISORDER (AUD) is the official diagnostic name for addiction to alcohol. It is caused by genetic and environmental factors with approximately the same amount of contributions from each. AUD is associated with a number of psychiatric, medical, and social problems. It is the 4th leading cause of preventable deaths. There are several effective types of psychotherapy, three FDA approved medications, and two more that are supported by research but not yet approved by the FDA (however, they can be legally prescribed now). Also, Alcoholics Anonymous remains a powerful means of attaining and maintaining sobriety. To learn more about this topic, touch the box below to be taken to my WordPress blog on this topic.

My company iNGENu CRO produced a white-paper highlighting the pitfalls & pain points of designing and executing a Clinical Study within Depression. Depression is a Mental Health condition that has a spectrum of related sub-categories; according to DSM-V (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5), they are categorized as follows: - ➖ Major Depressive Disorder ➖ Treatment Resistant Depression ➖ Persistent Depressive Disorder ➖ Bipolar Disorder ➖ Seasonal Affective Disorder (SAD) ➖ Psychotic Depression ➖ Peripartum (Postpartum) Depression ➖ Premenstrual Dysphoric Disorder (PMDD) ➖ 'Situational' Depression One of the many challenges of clinical studies within these Indications is the significant Placebo response rate. There has been minimal innovation successes in Drug Development within the mental health space outside of SSRI's & SNRI's, TCA's & MAIO's - which all come with huge side-effect profiles and a significant challenge for patients withdrawing / tapering the medication when they wish to discontinue. There are a flurry of Clinical Trials underway studying the potential of Psychedelic compounds and their effectiveness as 5-HT2A agonists on several Depression indications, such as TRD, MDD, PMDD and many more. iNGENu CRO have a deep understanding of the requirements for designing and conducting robust clinical studies within this challenging area of medicine. Download the article here to discover: more: https://lnkd.in/egcrx8nf #clinicaltrials #clinicalresearch #depressiontreatment

Drinking alcohol can cause progressive changes in the structure and function of the brain. These changes can compromise brain function and drive the transition from controlled, occasional use to alcohol use disorder. https://buff.ly/43dhqi5 #hocomd #alcoholsafety #brainfunction

Olanzapine for tardive dyskinesia; causes and uses Involuntary neurological movement disorder known as tardive dyskinesia (TD) is brought on by the use of medications that block dopamine receptors and are recommended to treat gastrointestinal or mental disorders. The brain region known as the striatum may experience biochemical changes as a result of long-term usage of certain medications. It is unknown why some users of these medications develop tardive dyskinesia while others do not. A more severe variation of tardive dyskinesia known as tardive dystonia is characterized by a predominance of slower twisting movements of the neck and trunk muscles. read more : https://lnkd.in/dbhEYvHw